Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma, Skin cancer
Closed
Phase 3
This study is looking at how best to manage fever that the combination of dabrafenib and trametinib can cause. It is for people whose:
melanoma cells have a change in a gene called BRAF
melanoma has either grown into surrounding tissues or and they have had surgery to remove this
Recruitment start: 24 August 2018
Recruitment end: 1 September 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Pippa Corrie
Novartis
Last reviewed: 2 September 2019
CRUK internal database number: 15681
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
